Business Context and Reporting Period
Company: Centrus Energy Corp.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Business Overview: Centrus operates two primary segments: (1) LEU, supplying low-enriched uranium components to commercial utilities globally, and (2) Technical Solutions, providing uranium enrichment and technical services to the U.S. government and private sector. The company is the only U.S. entity with an NRC license to produce High-Assay Low-Enriched Uranium (HALEU) and is currently operating a demonstration facility in Piketon, Ohio, under contract with the Department of Energy (DOE).
Key Financial Metrics
| Metric ($ millions) | 2024 | 2023 | Change |
|---|---|---|---|
| Total Revenue | 442.0 | 320.2 | +38% |
| Gross Profit | 111.5 | 112.1 | -1% |
| Operating Income | 48.0 | 52.4 | -8% |
| Net Income | 73.2 | 84.4 | -13% |
| Cash & Equivalents | 671.4 | 201.2 | +234% |
| Working Capital | 668.4 | 214.3 | +212% |
| Total Debt (Long-term) | 472.5 | 89.6 | +427% |
Note: Net Income includes significant non-operating components of net periodic benefit income ($14.7 million in 2024 vs. $23.2 million in 2023) driven by pension plan settlements and actuarial gains.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 38% to $442.0 million. The LEU segment grew 30% (driven by a 70% increase in uranium revenue and 19% in SWU revenue), while the Technical Solutions segment surged 80% due to the transition of the HALEU Operation Contract from Phase 1 (cost-share) to Phase 2 (cost-plus-incentive-fee).
- Margin Compression: Despite revenue growth, Gross Profit remained flat. LEU segment gross profit declined 11% due to a specific loss-making contract with a single customer, which accounted for 87% of the margin decrease. Technical Solutions gross profit increased 151%.
- Liquidity Expansion: Cash and cash equivalents more than tripled to $671.4 million, primarily due to the November 2024 issuance of $402.5 million in 2.25% Convertible Notes and $54.7 million in ATM equity offerings.
- Debt Structure: Long-term debt increased significantly following the issuance of the 2.25% Convertible Notes due in 2030. The company also holds 8.25% Notes maturing in February 2027.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Guidance
Centrus does not provide specific numerical financial guidance. Management anticipates adequate liquidity for at least the next 12 months. The company is focused on securing task orders under three new DOE IDIQ contracts (HALEU Deconversion, HALEU Production, and LEU Production) with a combined potential value of $3.4 billion. However, the timing and scope of these task orders remain uncertain.
Material Risks and Contingencies
- Geopolitical Supply Chain Disruption: The company relies heavily on TENEX (Russia) for over 50% of its LEU supply through 2027. Operations are impacted by the U.S. Import Ban Act (effective August 2024) and the Russian Decree (effective November 2024), which rescinded TENEX's general export license. Centrus has received waivers for 2024-2025 deliveries but faces uncertainty regarding 2026-2027 waivers and TENEX's ability to secure specific export licenses.
- Government Funding Uncertainty: Future growth depends on U.S. government appropriations. Executive Order 14154 (issued January 20, 2025) paused federal funding distribution pending review, creating uncertainty for IRA-funded contracts.
- HALEU Production Constraints: Phase 2 of the HALEU Operation Contract was extended to June 30, 2025, due to delays in the delivery of 5B storage cylinders by the DOE. Production targets were not met in 2024 due to this shortage.
- Customer Concentration: The ten largest customers represented 75% of total revenue in 2024. Two customers alone represented 33% of total revenue.
Unusual Items
- Pension Settlements: The company recognized $16.8 million in income in 2024 related to the transfer of pension obligations to insurers, recorded as non-operating benefit income.
- Tax Valuation Allowance: Centrus released $16.6 million of its federal valuation allowance in Q4 2024 based on improved visibility of future income, though a significant allowance ($365.7 million) remains.
Key Facts for Investor Verification
- Waiver Status: Verify the status of the third waiver request filed in December 2024 for Russian LEU imports in 2026-2027 and the issuance of specific export licenses by Russian authorities for TENEX shipments.
- DOE Task Orders: Monitor the issuance of task orders under the HALEU Production, LEU Production, and HALEU Deconversion contracts, as revenue recognition depends on these specific awards.
- Executive Order Impact: Assess the impact of Executive Order 14154 on the release of Inflation Reduction Act (IRA) funding for the company's government contracts.
- Convertible Note Conversion: Review the terms of the 2.25% Convertible Notes, specifically the conditional conversion triggers that could force cash settlement or dilution.
- HALEU Cylinder Supply: Confirm the resolution of the 5B cylinder supply chain issues to ensure Phase 2 production targets are met by the June 2025 deadline.